Treace Medical Concepts TMCI Cash Flow Statement (2020-2026)

NASDAQ TMCI
$4.46 -0.10 (-2.19%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-199.46M-6.62M-34.89M-15.23M-12.09M-4.05M-13.58M-12.37M-17.54M-6.38M-18.75M-21.32M-15.38M-0.87M-16.05M-17.52M-16.38M-6.96M-20.85M-18.47M
Depreciation and Depletion (Quarter)
2.30M1.50M
Share-based Compensation (Quarter)
6.46M
Asset Writedowns and Impairment (Quarter)
0.16M0.03M-0.23M0.16M0.45M0.04M0.04M0.00M0.35M0.16M2.05M0.17M0.57M0.50M0.08M-0.07M
Cash from Operations (Quarter)
-4.70M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.01M
Amortization of Deferred Charges (Quarter)
0.24M
Depreciation & Amortization (CF) (Quarter)
1.89M
Change in Working Capital
Change in Receivables (Quarter)
-1.50M
Change in Inventory (Quarter)
3.18M
Change in Account Payables (Quarter)
2.52M
Change in Accured Expenses (Quarter)
2.75M
Other Working Capital Changes (Quarter)
1.67M
Investing Activities
Capital Expenditures (Quarter)
2.20M
Change in Acquisitions & Divestments (Quarter)
11.87M
Cash from Investing Activities (Quarter)
7.07M
Financing Activities
Other financing activities (Quarter)
0.01M
Cash from Financing Activities (Quarter)
0.70M
Additional items
Change in Cash (Quarter)
3.07M
Free Cash Flow (Quarter)
-6.90M
Net Cash Flow (Quarter)
3.07M